YOUR ENERGY SYSTEMS, LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 9246
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0281,714 METHOD OF TREATMENT USING LIPOSOMALLY FORMULATED REDUCED GLUTATHIONE TO COOPERATE WITH IL-10 TO MODULATE INFLAMMATORY RESPONSE TRIGGERED IN HIV+ AND TB IMMUNE-COMPROMISED DIABETIC PATIENTSSep 28, 15Oct 05, 17[A61K]
2017/0000,841 TREATMENT OF KLEBSIELLA PNEUMONIAE WITH LIPOSOMALLY FORMULATED GLUTATHIONEAug 19, 16Jan 05, 17[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9913801 Treatment of evolving bacterial resistance diseases including Klebsiella pneumoniae with liposomally formulated glutathioneMar 15, 13Mar 13, 18[A61K, C12Q]
9421238 Treatment of klebsiella pneumoniae with liposomally formulated glutathioneFeb 14, 14Aug 23, 16[A61K]
8679530 Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, prepartion, for reversal and prevention of oxidation of cholesterol and of low density lipoproteinOct 26, 06Mar 25, 14[A61K]
8349359 Liposomal formulation for oral administration of glutathione (reduced)Nov 06, 05Jan 08, 13[A61K]
8252325 Liposome-encapsulated glutathione for oral administrationFeb 15, 12Aug 28, 12[A61K, A01N]
8147869 Liposome-encapsulated glutathione for oral administrationAug 31, 11Apr 03, 12[A61K, A01N]
8114913 Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with DHEA for the treatment of smallpoxJun 18, 09Feb 14, 12[A61K, A01N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0158,308 TREATMENT OF MULTIPLE EVOLVING BACTERIAL RESISTANCE DISEASES WITH LIPOSOMALLY FORMULATED GLUTATHIONEAbandonedAug 14, 14Jun 09, 16[A61K]
2014/0193,485 ORALLY ADMINISTRABLE LIPOSOMALLY ENCAPSULATED REDUCED GLUTATHIONE, WITH ACE INHIBITORS FOR REVERSAL AND PREVENTION OF OXIDATION OF CHOLESTEROL AND OF LOW DENSITY LIPOPROTEINAbandonedFeb 05, 14Jul 10, 14[A61K]
2014/0141,071 ORALLY ADMINISTRABLE LIPOSOMALLY ENCAPSULATED REDUCED GLUTATHIONE, WITH N-O ENHANCING COMPOUNDS FOR REVERSAL AND PREVENTION OF OXIDATION OF CHOLESTEROL AND OF LOW DENSITY LIPOPROTEINAbandonedJan 27, 14May 22, 14[A61K]
2013/0129,815 LIPOSOMAL FORMULATION FOR ORAL ADMINISTRATION OF GLUTATHIONE (REDUCED) VIA GEL CAPSULEAbandonedDec 31, 12May 23, 13[A61K]
2012/0219,616 LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESISAbandonedFeb 08, 12Aug 30, 12[A61K, A61P]
2012/0141,608 SYSTEMIC ADMINISTRATION OF NAC AS AN ADJUNCT IN THE TREATMENT OF BIOTERROR EXPOSURES SUCH AS ANTHRAX, VIRUS OR RADIATION AND USE IN COMBINATION WITH DHEA FOR THE TREATMENT OF VIRUSESAbandonedJun 18, 09Jun 07, 12[A61K, A61P]
2007/0053,970 LIPOSOMAL FORMULATION FOR ORAL ADMINISTRATION OF GLUTATHIONE (REDUCED) AND/OR METHYLCOBALAMINE FOR DISEASES RELATED TO GLUTATHIONE DEFICIENCY AND DEFICIENCY OF THE METHIONINE REMETHYLATION PATHWAYAbandonedMay 24, 06Mar 08, 07[A61K]
2004/0022,873 Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as anthrax, smallpox or radiation and for vaccination prophylaxis, and use in combination with DHEA for the treatment of smallpox and other virusesAbandonedNov 07, 02Feb 05, 04[A61K]
6534540 Combination and method of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitorExpiredJul 25, 01Mar 18, 03[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.